Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports


According to PersistenceMarketResearch, the global neurostimulation devices market is slated to witness a CAGR of more than 15% between 2020 and 2030.

Market Snapshot

The age-old neurostimulation systems meant for preclinical research are likely to be bulky as well as invasive as they need wired interfaces/batteries. The ongoing trend pertains to ultrasound-powered piezoelectric neural stimulators that function by conversion of ultrasound energy into electrical charge. Plus, they do have longer operational lifetimes to have a stable, long-term neural interface, thereby promising clinical translation. 

How is the market spread?

By functionality, the neurostimulation devices could be categorized into gastric electric stimulator, deep brain stimulator, sacral nerve stimulator, spinal cord stimulator, and vagus nerve stimulator (invasive and non-invasive). The application areas include Parkinson’s disease, gastroparesis, dystonia, depression, urinary and fecal incontinence, essential tremor, epilepsy, and pain management.


North America holds the largest market share with growing incidences of the neurological diseases along with increase in geriatric population. Plus, junk food consumption and alcoholism are there to add to demand of these devices. Europe stands second herein. The Asia-Pacific is expected to grow at the fastest pace in the years to come. This could be credited to the increase in awareness regarding disorders related to brain. 

Competitive Landscape

The key market participants include bayer, Abbott, IntraPace, Boston Scientific Corporation, Medtronic, Laborie, NeuroPace, SPR Therapeutics, Nevro, and Neuronetics. Coming to developments, Abbott, in Sep 2019, did receive approval from the US FDA regarding Proclaim XR recharge free neurostimulation device. NeuroPace RNS System is already in great demand for the treatment of drug-resistant focal epilepsy. Likewise, Abbott’s “Proclaim” series are inclusive of devices designed for delivering SCS (Spinal Cord Stimulation) to treat chronic pain along with DRG (dorsal root ganglion) stimulation for those suffering from causalgia (nerve pain that follows injury or surgery). Its Infinity DBS (Deep Brain Stimulation) system makes use of mild electric pulses for alleviating symptoms pertaining to Parkinson’s disease with essential tremor. 

To Know More about Report @

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts